Support- professional: other
Ended Awarded Last action
- Contract number
- HHSN268201200015I
- Awardee
-
New York Stem Cell Foundation Inc. UEI ZCKCL8KFL3B9
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Task orders
- 0
Award facts
- Last date to order 100% complete
- IDV ceiling
- $6,984,000.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 7 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The National Heart Lung and Blood Institute, a civilian agency within the U.S. Department of Health and Human Services, awarded an Indefinite Delivery Contract (IDC) to the New York Stem Cell Foundation, Inc., a non-profit organization, for $6,984,000. The contract supports professional services related to pluripotent stem cell research, with a period of performance from September 21, 2012 to September 23, 2015. Under this multiple-award IDC, the New York Stem Cell Foundation has generated induced pluripotent stem cell lines from patients with Alzheimer's and other neurological conditions, differentiated stem cells into insulin-producing beta cells, and expanded and validated neural progenitor cells derived from induced pluripotent stem cells. These services have been provided to support the agency's research objectives in areas such as Alzheimer's disease, psychiatric disorders, and regenerative medicine. The contract did not utilize any set-aside designations.
The IDC is a parent contract to the "Gene Insertion - Pluripotent Stem Cells 2012-2017" multiple-award IDIQ, which allows the National Heart Lung and Blood Institute to issue task orders for a variety of stem cell research services from the selected contractors. The contract aims to procure professional services to advance the agency's stem cell research programs, leveraging the New York Stem Cell Foundation's expertise in areas such as stem cell differentiation, functional experiments, and disease modeling.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract HHSN268201200015I?
HHSN268201200015I was awarded to New York Stem Cell Foundation Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on September 21, 2012.
How much is contract HHSN268201200015I worth?
HHSN268201200015I's own ceiling is $6,984,000.
Who can order from contract HHSN268201200015I?
HHSN268201200015I is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract HHSN268201200015I part of a contract vehicle?
Yes. HHSN268201200015I is part of Gene Insertion - Pluripotent Stem Cells 2012-2017.
Was contract HHSN268201200015I competed?
The extent of competition for HHSN268201200015I was full and open competition. The government received 7 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV